DAVID P. LUCI - 27 Jul 2022 Form 4 Insider Report for Acurx Pharmaceuticals, Inc. (ACXP)

Role
President and CEO, Director, 10%+ Owner
Signature
/s/ Kostantinos Skordalos, Power of Attorney For: David P. Luci
Issuer symbol
ACXP
Transactions as of
27 Jul 2022
Transactions value $
$75,001
Form type
4
Filing time
29 Jul 2022, 17:01:37 UTC
Previous filing
22 Nov 2021
Next filing
24 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACXP Common Stock Purchase $75,000 +19,737 +2% $3.8 1,028,460 27 Jul 2022 Direct
holding ACXP Common Stock 15,083 27 Jul 2022 By spouse
holding ACXP Common Stock 35,000 27 Jul 2022 By child

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACXP Warrants for Common Stock Purchase $0 +19,737 $0 19,737 27 Jul 2022 Common Stock 19,737 $3.55 Direct
transaction ACXP Warrants for Common Stock Purchase $0 +19,737 $0 19,737 27 Jul 2022 Common Stock 19,737 $3.55 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.